A retrospective, observational study to investigate the therapeutic value of dexmedetomidine (dexdor®) in clinical practice (DexBOS)

Study identification

• EU PAS number:
  EUPAS7037
• Study ID:
  30353
• Official title and acronym:
  A retrospective, observational study to investigate the therapeutic value of dexmedetomidine (dexdor®) in clinical practice (DexBOS)
• DARWIN EU® study:
  No
• Study countries:
  Belgium
• Study description:
  This study will retrospectively collect data from medical records on the therapeutic use of patients who have been treated with dexdor since it's introduction to the study sites and compare this to control patients who did not receive dexdor.
• Study status:
  Finalised

Research institutions and networks

Institutions

Multiple centres

Multiple centres: 2 centres are involved in the study

Study timelines

Date when funding contract was signed

Planned:19/06/2014

Actual:09/07/2014

Study start date

Planned:01/08/2014

Actual:14/08/2014

Date of final study report

Planned:02/05/2017

Actual:15/02/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Orion Pharma

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable